• Suggest a topic

    Is there a certain topic you want to learn more about, or topics you think we should cover? Let us know.
    Use this form to submit your suggestions.

    Thanks!

    Thank you for suggesting a topic. We will take into consideration.

    error key Required fields not completed correctly.

Speakers of Our Conferences

  • Home
  • /Speakers of Our Conferences

At CYPIN, we search year-round for experts and game changers with insights to solve some of the leading challenges in the industry. Our presenters run some of the world’s most reputable organizations. They are the leading executives that others look to for leadership. Some of these remarkable presenters include:

3rd Annual U.S.-CHINA PHARMA Conference

Anil Namboodiripad
Vice President, External R&D and Global Marketing, Proprietary Products, Dr. Reddy’s Laboratories

Bill Farley
Director, Business Development, Discovery, Wuxi AppTec Inc.

Chia Wen Lee Grossman
Head of Emerging Market Access, Biogen Idec

Curtis Tyree
VP of Operations, HUYA Bioscience Internationa

Cyrus A. Chowdhury
CEO, CB Partners

Eugene Buff, MD, Ph.D.
Primary Care Innovation Consulting, UsTech Discovery

Fiona An
Director, Emerging Markets Clinical Development, Pfizer

G. Steven Burrill
CEO, Burrill & Company

Henry Gu
Counsel, WilmerHale

Karen LaRochelle
China BD Professional

Kenneth J. Holroyd
Kenneth J. Holroyd, M.D., MBA, Assistant Vice Chancellor for Research
Vanderbilt University Medical Center

Kimberly Ha
Global Editor, Biopharm Insight (Financial Times Group)

Les Funtleyder
Healthcare Strategist, Polliwog Investment Advisors

Linda Zhao, Ph.D.
President, Draco Healthcare Inc.

Mark C. Tang, Ph.D., MBA
Chairman, WT Global Capital, GCA Therapeutics, World Biotechnology Forum

Mark Cohen
Visiting Professor of Law, Fordham Law School; Publisher, ChinaIPR.com (pending)

O. Prem Das
Chief Research Business Development Officer, Dana-Farber Cancer Institute

Philip Zhang
Co-Managing Principal, Milstein Zhang & Wu LLC

Robert Wenslow Jr.
Vice President Business Development, Crystal Pharmatech

R. Stephen Porter, PharmD.
Chief Scientific Officer, Dragon Bio-Consultants, Ltd.

Terry Jacobs
Co-Founder and Partner, JacobsWyper Architects

Vincent Liu
Chief Representative New York, Shanghai Fosun Pharmaceutical Group

Wei Zhang, Ph.D.
Head, Corporate Development, Good Start Genetics

William Looney
Editor in Chief, Pharma Executive Magazine

Yuan-Hua Ding
Head of External R&D Innovation and Sr. Director, Pfizer Worldwide R&D

8 Tips to Alleviate IP Concerns Around China Pharma Products eSummit

Jiwen Chen, J.D., LLM
Attorney-at-law/Asia Practice Director, Jacobson Holman PLLC

Benjamin Liu, J.D.,
Assistant Professor, China IP Resource Center, John Marshall Law School

Robert Wenslow, Jr.
Vice President of Business Development, Crystal Pharmatech

 

1st Annual Software Design for Medical Devices Conference

Abe Mamaghani
Development R&D Manager, Abbott Laboratories

Arnab Ray
Research Scientist, Fraunhofer Center for Experimental Software Engineering

Adam Darmstadt
TechnicalSoftware Development Manager, Bio-Rad Laboratories

Brian Shoemaker, Ph.D.
Principal Consultant ShoeBar Associates

Dale Hallerberg P.E.
TechnicalManager-Medical Test, TÜV Rheinland North America

Erik Hilliard
Project Lead Engineer, Sterling Medical Devices

Justin Heyl
Program Manager, Intertek Consulting Services

Juergen Stettin M.D., Ph.D.
CEO, PROSYSTEM AG, Hamburg; Chairman of German Scientific Hospital Organization (WGKT)

Oliver P. Christ
CEO Healthcare PROSYSTEM AG, Hamburg Member of International Standardization Group for IEC 62366

Richard C. Chapman
General Engineer, Center for Device and Radiological Health (CDRH), Food and Drug Administration (FDA)

Ron Rammage, PMP
Software Engineering Manager, Abbott Medical Optics

Sathish Ramkumar
Sr. Manager, Software Development, Imaging Clinical Applications and Platforms (ICAP)-NM Philips Healthcare

Stephen McRoberts
Principal Engineer for Medical Regulatory & Proprietary Compliance Underwriter Laboratories

Stephen B. Wilcox, Ph.D., FIDSA
Principal and Founder Design Science

Tajudeen Oladele
Consultant-Global Regulatory Compliance, Terumo Cadiovascular

Thomas L. Bento
Sr. Regulatory Consultant, Certified Compliance Solutions, Inc

 

2nd Annual Pharma Market Forecasting for China Workshop

George Foldes
Director, Strategic Business Analytics, Vifor Pharma

Neesha Suvarna
Consultant, Kantar Health

Dake Wang
Sr. Vice President, Epidemiology, Draco Healthcare Consulting LLC

Buyong Zhang
General Manager, China Medical Economic Institute

Linda Zhao, Ph.D., MBA
President and CEO, Draco Healthcare Consulting LLC.

2nd Annual U.S.-CHINA PHARMA Conference

Daofen Chen, Ph.D.
Program Director, NINDS/NIH Neuroscience Center

Rajeev Dadoo
Partner, SR One

Yuan-Hua Ding
Head of External R&D Innovation and Sr. Director, Pfizer Worldwide R&D

Bill Farley
Director, Business Development, Discovery, Wuxi AppTec Inc.

Danchen Gao, Ph.D.
Intellectual Property Strategy, Pharmaceutical Products Group, Abbott Laboratories

Murali Gopalakrishna
Head, Global External Research, GPR&D, Abbott Laboratories

David Jiang, Ph.D., MBA
Managing Director, BIOCOM China Consulting

Joanne Jiang
Co-Founder, VP Business Development and Project Management, Fountain Medical Development

Joanne JiangShengfang Jin, Ph.D.
Head of Strategic Outsourcing and Sr. Director of Biology, Agios Pharmaceuticals Inc.

Dr. Zhifeng Long
President, Chinese BioPharmaceutical Association; and Founder, President, and CEO, Personal Diagnostix Inc.

Katherine Lee
Sr. VP, Business and Partnership Development, Pharmaron Inc.

Karen LaRochelle
Global Head, Business Analysis and Negotiations, Head Business Development, China, Bristol-Myers Squibb
Stanton Lovenworth
Counsel, O’Melveny & Myers

Vincent Liu
Chief Representative New York, Shanghai Fosun Pharmaceutical Group

Joe Powers, Ph.D., MBA, MBE
Managing Director, Office of the Vice Provost for Research; Executive Director, Center for Neuroscience & Society, University of Pennsylvania

Jeffrey Rosedale
Woodcock Washburn LLP

Melvin Reichman, Ph.D.
President and CSO, LIMR Chemical Genomics Center (LCGC)

Richard Racine
Partner, Finnegan

Jeff Ulmer, Ph.D.
Global Head of External Research, Novartis Vaccines & Diagnostics

Wenseng “Wendy” Pan, J.D., Ph.D.
Counsel, O’Melveny & Myers

Robert Wenslow Jr.
Vice President Business Development, Crystal Pharmatech

Ying Wang, Ph.D.
Senior Scientist III, Scaffold Oriented Synthesis Group, Advanced Technology, GPRD, Abbott Laboratories

Ruo Xu
Principal Scientist, Merck & Co.

Austin W. Zhang
Senior Corporate Counsel, Legal Division-Intellectual Property, Pfizer Inc.

Litao Zhang
Executive Director, Lead Evaluation and Mechanistic Biochemistry, Bristol-Myers Squibb

Xuefeng Zhang
Sales Executive, Genewiz

Market Access, Pricing and Reimbursement Strategies eSummit

Maria Avxentyeva
Deputy Director, Research Institute of Clinico-economic Expertise and Pharmacoeconomics, Russian State Medical University

Monica Martin de Bustamante
Principal, Global Market Access, Insight Strategy Advisors

Chia Wen Lee Grossman
Director Emerging Markets, Market Access, Biogen Idec

 

Branded Generics for Emerging Markets Conference

Woody Bryan
Vice President, Business Development and Project Management, Supernus Pharmaceuticals

Cyrus A. Chowdhury
Vice President, Global Market Access Insight Strategy Advisors

Ana Claudia Mamede Carneiro
Partner, Industry Property Agent, Chemical Engineer, Dannemann Siemsen

Anjan Chatterji, MBA, J.D., LL.M.
Life Sciences Specialist, Deloitte Financial Advisory Services (New York)

Asa Cox
Founder, Generic Pharma 2.0 Inc.

Jiwen Chen, J.D., LL.M.
Attorney-at-law/ Asia Practice Director, JACOBSON HOLMAN PLLC

Richard Dicicco
Chairman, Harvest Moon Pharmaceuticals USA, Inc.

Susan Dexter
Principal Consultant, Latham BioPharm Group Inc.

Andrew Forman
Global Life Sciences Sector Resident, Transaction Advisory Services, Ernst & Youn

Neil Grubert, MA
Intellectual Director of Pricing and Reimbursement, Decision Resources

Michael Latwis, MBA
Sr. Corporate Analyst, Decision Resources

Arvind Mishra, Ph.D.
President, Corporate QC/QA a,d Regulatory Affairs, Parabolic Drugs Ltd.

Ashish Menocha
Head of International Markets, Abdi Ibrahim

Janeth Mora, PharmD.
Managing Partner, LinkPharma

Peter Munson
Partner, Wilson Sonsini Goodrich & Rosati

Elias Rios Navarro
Partner, Arochi Marroquin & Linder, S.C.

Lulu Pickering, Ph.D.
Sr. Program Manager,Pharmaceutical Industry Dynamics, Decision Resources

Valeria Povolotsky, Ph.D.
Vice President, Global Partnering, R-Pharm; CEO, Advanced Bio Design

Daisy Rivera-Muzzio
President, Acumen BioPharma

Anita Shaw, Ph.D.
Branded Generics Technical Director, Merck & Co.

Nikolay Savchuk
President and CEO, ChemDiv, Inc.

Seth Silber
Partner, Wilson Sonsini Goodrich & Rosati

Stuart Williams
Partner, Wilson Sonsini Goodrich & Rosati

Xiang (Andy) Yu, Ph.D., J.D.
Life Sciences Specialist, Deloitte Financial Advisory Services (New York)

Wei Zhang, Ph.D.
Principal, Safeguard Scientifics, Inc.

 

1st Annual Pharma Market Forecasting for China Workshop

Monica Martin de Bustamante
Principal, Global Market Access, INSIGHT STRATEGY ADVISORS

Cyrus A. Chowdhury
Vice President, Global Market Access, INSIGHT STRATEGY ADVISORS

Michael DeStefano, Ph.D.
Senior Consultant, Forecasting and Modeling, KANTAR HEALTH

George Foldes
Director, Strategic Business Analytics, VIFOR PHARMA

Todd Johnson
Senior Director, Forecasting, KANTAR HEALTH

Linda Zhao, Ph.D., MBA
President and CEO, DRACO HEALTHCARE CONSULTING LLC

 

1st Annual U.S.-CHINA PHARMA Conference


Cyrus A. Chowdhury
Vice President, Global Market Access Insight Strategy Advisors

David C. Christiani, M.D., M.P.H., M.S.
Elkan Blout Professor of Environmental Genetics, Departments of Environmental Health and Epidemiology, Harvard School of Public Health; Professor of Medicine, Harvard Medical School

Peng Chen
Partner, Morrison & Foerster LLP

Yiyou Chen, Ph.D.
Chief Scientific Officer, Crown Bioscience Inc.

Rajeev Dadoo
Partner, SR One

Dr. Frank Floether
Dr. Floether Consulting

Charles Hsu, Ph.D., MBA
Venture Partner, Bay City Capital

Jing-Shan Hu, Ph.D.
Director of Licensing & External Research (Mainland China, Hong Kong, & Taiwan), Merck & Co.

Pearl Huang, Ph.D.
Founder and CSO, BeiGene Ltd

Joanne Jiang, PhD, MBA
Co-Founder, VP, Business Development and Project Management, Fountain Medical Development

John Jin
Vice President Business Development, TaiGen Taiwan

Benjamin Liu, J.D.
Assistant Professor, China IP Resource Center, John Marshall Law School

Christopher Laing, MRCVS, Ph.D
Vice President, Science and Technology, University City Science Center

Evan Loh, M.D., FACC, FAHA
Sr. Vice President, WRD Development and Strategic Operations, Pfizer Worldwide Research & Development

Mike Liu, Ph.D., MBA
Head of Global Business Development, Hengrui Pharmaceuticals China

Geoff Meyerson
Founder and Managing Director, Locust Walk Partners

Drew Natenshon
Head US Research Strategy and Operations, Novartis Vaccines & Diagnostics

R.Stephen Porter, PharmD.
Chief Scientific Officer, Dragon Bio-Consultants, Ltd.

Wenseng “Wendy” Pan, J.D., Ph.D.
Associate, Morgan Lewis & Bockius LLP

Melvin Reichman, Ph.D.
Director, LIMR Chemical Genomics Center (LCGC)

Annette Tobia, Ph.D., J.D.
Founder & CEO, Dynamis Therapeutics and Dynamis Skin Science

Wim Vandenhouweele
Executive Director, Global Vaccines & Commercial Development, Merck & Co.

George Wilding, MD
Director, UWCCC; Assistant Dean for Oncology, Anderson Professor of Medicine, University of Wisconsin School of Medicine and Public Health

Jingsong Wang, M.D., FACR
President, SAPA-GP; Director, Discovery Medicine & Clinical Pharmacology, Bristol-Myers Squibb

Qingyi Wei, MD, Ph.D.
Professor of Epidemiology, The University of Texas M.D. Anderson Cancer Center

Patricia Weeks
Founder and President, Weeks Consulting

Xiang Wang, Ph.D., J.D.
Partner, Intellectual Property, Orrick, Herrington & Sutcliffe LLP (Beijing)

Xiao Yang
President, CRV Biotech Inc.

Wei Zhou, MD, Ph.D.
Director, Molecular Epidemiology, Pfizer Oncology; Co-Chair of Academic Relationship, US Chinese Anti-Cancer Association

Wei Zhang, Ph.D.
Principal, Safeguard Scientifics, Inc.